No increase seen in predicted rates of all-cause mortality, admissions for ambulatory care-sensitive conditions
Read More »HealthDay.com
Liraglutide Exerts Weight Loss-Independent, GLP-1R-Dependent Effects
Prior to weight loss, liraglutide improves insulin sensitivity; reductions in fasting and postprandial glucose also seen
Read More »Artificial Intelligence Increases Diabetic Eye Exams in Youth With Diabetes
Diabetic eye exam completion rate higher for those randomly assigned to autonomous artificial intelligence diabetic eye exam at point of care
Read More »FDA Finds No Evidence Linking Wegovy, Ozempic to Suicidal Behaviors
However, the agency noted officials cannot rule out that 'a small risk may exist,' and it will continue to investigate
Read More »Fracture Risk Up With Prediabetes Before Menopause Transition
Increased risk of fracture after adjustment for confounding variables, including bone mineral density
Read More »Anthropometric + Biochemical Markers May Aid Gestational Diabetes Diagnosis
Authors say there is a gap in the literature on clinical, biochemical, and sociocultural factors
Read More »Risk for Suicidal Ideation Not Increased With Semaglutide
No increased risk for suicidal ideation seen with semaglutide versus non-GLP1R agonist antiobesity medications
Read More »Preconception Psychological Stress Linked to Abnormal Glucose Levels
Women in second and third versus first tertile of psychological stress have higher probabilities of having abnormal glucose during pregnancy
Read More »New Side Effects Reported for GLP-1 RA Weight-Loss Drugs
FDA is investigating reports of hair loss, aspiration, and suicidal thoughts among people taking the medications
Read More »Food Insecurity Declined in 2021 Versus 2019 in Low-Income Adults
Greater decrease in food insecurity seen among the subset of individuals receiving SNAP benefits
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.